These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 34230984)
21. Infusion of haploidentical hematopoietic stem cells combined with mesenchymal stem cells for treatment of severe aplastic anemia in adult patients yields curative effects. Ding L; Han DM; Zheng XL; Yan HM; Xue M; Liu J; Zhu L; Guo ZK; Mao N; Ning HM; Wang HX; Heng Zhu Cytotherapy; 2022 Feb; 24(2):205-212. PubMed ID: 34799271 [TBL] [Abstract][Full Text] [Related]
22. Nonmyeloablative peripheral blood haploidentical stem cell transplantation for refractory severe aplastic anemia. Clay J; Kulasekararaj AG; Potter V; Grimaldi F; McLornan D; Raj K; de Lavallade H; Kenyon M; Pagliuca A; Mufti GJ; Marsh JC Biol Blood Marrow Transplant; 2014 Nov; 20(11):1711-6. PubMed ID: 25016195 [TBL] [Abstract][Full Text] [Related]
23. Long-term outcome of HLA-haploidentical hematopoietic SCT without in vitro T-cell depletion for adult severe aplastic anemia after modified conditioning and supportive therapy. Gao L; Li Y; Zhang Y; Chen X; Gao L; Zhang C; Liu Y; Kong P; Wang Q; Su Y; Wang C; Wang S; Li B; Sun A; Du X; Zeng D; Li J; Liu H; Zhang X Bone Marrow Transplant; 2014 Apr; 49(4):519-24. PubMed ID: 24464145 [TBL] [Abstract][Full Text] [Related]
24. A novel protocol for haploidentical hematopoietic SCT without in vitro T-cell depletion in the treatment of severe acquired aplastic anemia. Xu LP; Liu KY; Liu DH; Han W; Chen H; Chen YH; Zhang XH; Wang Y; Wang FR; Wang JZ; Huang XJ Bone Marrow Transplant; 2012 Dec; 47(12):1507-12. PubMed ID: 22635243 [TBL] [Abstract][Full Text] [Related]
25. Untreated Donor-Specific HLA Antibodies Are Associated With Graft Failure and Poor Survival After Haploidentical Transplantation With Post-Transplantation Cyclophosphamide in Pediatric Patients With Nonmalignant Disorders. Lima ACM; Bonfim C; Getz J; do Amaral GB; Petterle RR; Loth G; Nabhan SK; de Marco R; Gerbase-DeLima M; Pereira NF; Pasquini R Transplant Cell Ther; 2022 Oct; 28(10):698.e1-698.e11. PubMed ID: 35882362 [TBL] [Abstract][Full Text] [Related]
26. Analysis of allogeneic hematopoietic stem cell transplantation with high-dose cyclophosphamide-induced immune tolerance for severe aplastic anemia. Guo Z; Gao HY; Zhang TY; Liu XD; Yang K; Lou JX; He XP; Zhang Y; Chen P; Chen HR Int J Hematol; 2016 Dec; 104(6):720-728. PubMed ID: 27709450 [TBL] [Abstract][Full Text] [Related]
27. [Comparison of Frontline Haploidentical Hematopoietic Stem Cell Transplantation and Salvage Haploidentical Hematopoietic Stem Cell Transplantation for Patients with Severe Aplastic Anemia]. Xiao F; Liu Q; Fan D; Guo HX; Yan XQ; Zhao H; Liu L Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1683-1688. PubMed ID: 33067974 [TBL] [Abstract][Full Text] [Related]
28. The role of donor type and pre-transplant immunosuppression on outcomes of hematopoietic stem cell transplantation in children and young adults with severe aplastic anemia. Kashif R; Horn B; Milner J; Joyce M; Dalal M; Lee JJ; McNerney K; Cline J; Fort J; Castillo P; Galvez J; Alperstein W; Ligon J; Ziga E; Crawford D; Chellapandian D Pediatr Transplant; 2024 Jun; 28(4):e14784. PubMed ID: 38766976 [TBL] [Abstract][Full Text] [Related]
29. Clinical Utility of the Detection of the Loss of the Mismatched HLA in Relapsed Hematological Patients After Haploidentical Stem Cell Transplantation With High-Dose Cyclophosphamide. Muñiz P; Kwon M; Carbonell D; Chicano M; Bailén R; Oarbeascoa G; Suárez-González J; Andrés-Zayas C; Menárguez J; Dorado N; Gómez-Centurión I; Anguita J; Díez-Martín JL; Martínez-Laperche C; Buño I Front Immunol; 2021; 12():642087. PubMed ID: 33841425 [TBL] [Abstract][Full Text] [Related]
30. Hematopoietic stem cell transplantation with umbilical cord multipotent stromal cell infusion for the treatment of aplastic anemia--a single-center experience. Wang H; Wang Z; Zheng X; Ding L; Zhu L; Yan H; Guo Z Cytotherapy; 2013 Sep; 15(9):1118-25. PubMed ID: 23806238 [TBL] [Abstract][Full Text] [Related]
31. Haploidentical stem cell transplantation for aplastic anemia: the current advances and future challenges. Xu ZL; Huang XJ Bone Marrow Transplant; 2021 Apr; 56(4):779-785. PubMed ID: 33323948 [TBL] [Abstract][Full Text] [Related]
32. Unmanipulated haploidentical haematopoietic stem cell transplantation for children with severe aplastic anaemia. Zhu H; Luo RM; Luan Z; Lee V; Zhu YP; Luo CJ; Tang XF; Si YJ; Chen J Br J Haematol; 2016 Sep; 174(5):799-805. PubMed ID: 27263533 [TBL] [Abstract][Full Text] [Related]
33. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate. Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856 [TBL] [Abstract][Full Text] [Related]
34. Successful Salvage Therapy by Second Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in a Severe Aplastic Anemia Patient Presenting Donor-Specific Anti-HLA Antibodies After Graft Failure From Matched Sibling Donor HSCT: A Case Report and Review. Si Y; Zhang X; Bian M; Lin G; Wang L; Wang M; Zhang Y Transplant Proc; 2021 May; 53(4):1350-1354. PubMed ID: 33752903 [TBL] [Abstract][Full Text] [Related]
35. Who is the best haploidentical donor for acquired severe aplastic anemia? Experience from a multicenter study. Xu LP; Wang SQ; Ma YR; Gao SJ; Cheng YF; Zhang YY; Mo WJ; Mo XD; Zhang YP; Yan CH; Chen YH; Zhou M; Wang Y; Zhang XH; Liu KY; Huang XJ J Hematol Oncol; 2019 Sep; 12(1):87. PubMed ID: 31477147 [TBL] [Abstract][Full Text] [Related]
36. Donor-derived marrow mesenchymal stromal cell co-transplantation following a haploidentical hematopoietic stem cell transplantation trail to treat severe aplastic anemia in children. Wang Z-; Yu H-; Cao F-; Liu Z-; Liu Z-; Feng W-; Liu X-; Yu Y-; Xiao Y; Li L-; Zhou J Ann Hematol; 2019 Feb; 98(2):473-479. PubMed ID: 30341538 [TBL] [Abstract][Full Text] [Related]
37. Impact of cyclophosphamide dose of conditioning on the outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia from human leukocyte antigen-identical sibling. Mori T; Koh H; Onishi Y; Kako S; Onizuka M; Kanamori H; Ozawa Y; Kato C; Iida H; Suzuki R; Ichinohe T; Kanda Y; Maeda T; Nakao S; Yamazaki H Int J Hematol; 2016 Apr; 103(4):461-8. PubMed ID: 26910242 [TBL] [Abstract][Full Text] [Related]
38. Outcomes of haploidentical bone marrow transplantation in patients with severe aplastic anemia-II that progressed from non-severe acquired aplastic anemia. Liu H; Zheng X; Zhang C; Xie J; Gao B; Shao J; Yang Y; Wang H; Yan J Front Med; 2021 Oct; 15(5):718-727. PubMed ID: 34170455 [TBL] [Abstract][Full Text] [Related]
39. [Fludarabine-based increased-intensity conditioning regimen for allogeneic hematopoietic stem cell transplantation in acquired severe aplastic anemia]. Sun C; Lin X; Huang Y; Song C; Tao Y; Tu S; Fang J; Chen T; Sun C; Wu B Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):221-4. PubMed ID: 24666488 [TBL] [Abstract][Full Text] [Related]
40. Immunosuppressive therapy versus haploidentical transplantation in adults with acquired severe aplastic anemia. Xu ZL; Zhou M; Jia JS; Mo WJ; Zhang XH; Zhang YP; Wang Y; Li YM; Huang XJ; Wang SQ; Xu LP Bone Marrow Transplant; 2019 Aug; 54(8):1319-1326. PubMed ID: 30670825 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]